• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Now accepting nominations for the Fierce Innovation Awards - Submit your application today
Second quarter
Pharma

Of biopharma's top 25 companies, 9 had double-digit sales bumps

Biopharma sales boomed in Q2. Of the top 25 revenue companies, nine had YoY double-digit increases and 13 saw sequential increases of at least 10%.
Kevin Dunleavy Aug 12, 2026 11:47am
MA

Alfasigma gains drug, new territories with M&A play

Aug 12, 2026 11:23am
Eli Lilly

Lilly files lawsuits versus 6 sellers of retatrutide copycats

Aug 12, 2026 10:46am
drug recall FDA recall recall voluntary recall

Fresenius Kabi launches US recall of Actemra biosimilar

Aug 12, 2026 9:13am
Magnifying glass with pills on blue

Regulatory tracker: Akeso's ivonescimab wins key nod in China

Aug 12, 2026 9:13am
A smartphone showing Snapchats multi-CTA feature

Snapchat creates ad format to support pharma disclosure needs

Aug 12, 2026 2:10am
More News

WuXi AppTec wins temporary relief in DOD classification feud

Aug 11, 2026 11:33am

BridgeBio’s Attruby cruises toward blockbuster land

Aug 11, 2026 11:22am
Fierce Healthcare

Trump signs executive order to revise childhood vaccine schedule

Aug 10, 2026 6:00pm

Unapproved in US for decades, levosimendan stumbles in ph. 3

Aug 10, 2026 4:40pm
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings